| Anty-VEGF | vascular endothelial growth factor inhibitor |
| BCVA | best corrected visual acuity |
| CRT | central foveal thickness |
| DCP | deep capillary plexus |
| DD | disc diameter |
| DME | diabetic macular edema |
| DR | diabetic retinopathy |
| DRIL | disorganization of retinal inner layers |
| EDTA | ethylenediaminetetraacetic acid |
| ETDRS | Early Treatment Diabetic Retinopathy Study |
| FA | fluorescein angiography |
| FAZ | foveal avascular zone |
| HbA1c | glycated hemoglobin |
| HPLC | high-performance liquid chromatography |
| ILM | internal limiting membrane |
| IRMA | intraretinal microvascular abnormalities |
| MAs | microaneurysms |
| Max RT | maximum retinal thickness |
| MCP | middle capillary plexus |
| NGSP | National Glycohemoglobin Standardization Program |
| NVD | neovascularization at the disc |
| NVE | neovascularization elsewhere |
| OCT | optical coherence tomography |
| OCTA | optical coherence tomography angiography |
| OGTT | oral glucose tolerance test |
| SCP | superficial capillary plexus |
| SD-OCT | spectral domain optical coherence tomography |
| SRF | subretinal fluid |
| SSADA | split spectrum amplitude decorrelation angiography |
| SSI | signal strength index |
| VD | vessel density |
| VEGF | vascular endothelial growth factor |